Guardian Pharmacy Services, Inc.
GRDN
$29.28
-$0.06-0.20%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.39B | 1.33B | 1.28B | 1.23B | 1.17B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.39B | 1.33B | 1.28B | 1.23B | 1.17B |
| Cost of Revenue | 1.12B | 1.07B | 1.03B | 984.04M | 939.06M |
| Gross Profit | 274.32M | 260.48M | 253.62M | 244.37M | 231.85M |
| SG&A Expenses | 207.85M | 315.24M | 304.62M | 298.25M | 267.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.32B | 1.38B | 1.33B | 1.28B | 1.21B |
| Operating Income | 66.47M | -54.76M | -51.00M | -53.87M | -36.09M |
| Income Before Tax | 58.55M | -63.73M | -71.09M | -79.89M | -81.55M |
| Income Tax Expenses | 19.01M | 12.15M | 8.39M | 4.56M | 176.00K |
| Earnings from Continuing Operations | 39.53 | -75.88 | -79.48 | -84.44 | -81.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 705.00K | -6.34M | -11.77M | -16.25M | -18.90M |
| Net Income | 40.24M | -82.22M | -91.25M | -100.70M | -100.62M |
| EBIT | 66.47M | -54.76M | -51.00M | -53.87M | -36.09M |
| EBITDA | 88.22M | -33.86M | -30.72M | -34.10M | -16.76M |
| EPS Basic | 0.65 | -1.50 | -1.65 | -1.80 | -2.00 |
| Normalized Basic EPS | 0.68 | -0.69 | -0.75 | -0.88 | -1.09 |
| EPS Diluted | 0.64 | -1.51 | -1.66 | -1.81 | -2.00 |
| Normalized Diluted EPS | 0.67 | -0.69 | -0.75 | -0.89 | -1.09 |
| Average Basic Shares Outstanding | 248.26M | 247.28M | 246.37M | 184.33M | 122.29M |
| Average Diluted Shares Outstanding | 252.27M | 249.98M | 247.92M | 185.01M | 122.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -14.97% | -31.69% | -35.80% | -45.77% |